A study to assess effects of sildenafil drug in patients of raised blood pressure of lung circulatio
Phase 2
Completed
- Conditions
- Health Condition 1: null- secondary pulmonary hypertension
- Registration Number
- CTRI/2017/01/007686
- Lead Sponsor
- Department of cardiology King george medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 122
Inclusion Criteria
Patients with symptomatic secondary pulmonary hypertension with New York Heart Association (NYHA) functional class II-III with underlying aetiologies of pulmonary hypertension such as valvular heart disease, dilated cardiomyopathy, heart failure with preserved ejection fraction, chronic obstructive pulmonary disease and interstitial lung disease were included in the study.
Exclusion Criteria
Patients with primary pulmonary hypertension, hypotension, allergy to sildenafil, ischemic heart disease, on other vasodilators (ex. Nitrate), prior treatment with other anti PAH drugs, prior cardiac valve surgery, severe valve stenosis were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method